Endoscopy 2011; 43(11): 966-970
DOI: 10.1055/s-0031-1291427
DDW Highlights
© Georg Thieme Verlag KG Stuttgart · New York

Endoscopic diagnosis and treatment of upper gastrointestinal tumors

P. H. Deprez
Department of Gastroenterology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
› Author Affiliations
Further Information

Publication History

Publication Date:
04 November 2011 (online)

Early diagnosis, endoscopic differentiation of benign from malignant lesions, and removal of clinically significant tumors are increasingly considered to be major topics of interest in the upper gastrointestinal tract. This interest is mainly due to the development of better imaging tools and new resection techniques that fulfill surgical criteria. At this year’s Digestive Disease Week (DDW; 7 – 10 May 2011, Chicago, Illinois, USA), more than 500 abstracts were presented that focused on better imaging, training, safety issues, luminal stenting, and indications and results in endoscopic submucosal dissection (ESD). This review highlights a selection of clinically relevant reports of the upper gastrointestinal tract, excluding Barrett’s esophagus, which is covered in a separate report. Related abstracts that are not discussed in this review can be found in the additional references of interest.

 
  • References

  • 1 Uedo N, Ezoe Y, Muto M et al. Differential diagnosis of small gastric depressed lesions by magnifying narrow band imaging: a multicenter prospective randomized controlled trial. Gastrointest Endosc 2011; 73: AB146
  • 2 Yokoyama A, Inoue H, Ikeda H et al. NBI magnifying endoscopic classification for early gastric cancer; particularly focusing on micro-vascular pattern and surface glandular structure. Gastrointest Endosc 2011; 73: AB372-373
  • 3 Bisschops R, Bergman JJ, Willekens H et al. Endoscopic mucosal resection in the esophagus: how long is the learning curve?. Gastrointest Endosc 2011; 73: AB390
  • 4 Kobayashi N, Konishi J, Sekiguchi R. Learning curve for endoscopic submucosal dissection of large superficial colorectal tumors. Gastrointest Endosc 2011; 73: AB429
  • 5 Lim JH, Kim SG, Im JP et al. Do anti-platelet agents increase the risk of bleeding after endoscopic submucosal dissection of gastric tumors?. Gastrointest Endosc 2011; 73: AB319-AB320
  • 6 Maeda Y, Hirasawa D, Fujita N. Carbon dioxide insufflation reduces mediastinal emphysema after esophageal endoscopic submucosal dissection (ESD). Gastrointest Endosc 2011; 73: AB407
  • 7 Kim DH, Jung HY, Choi KD et al. Long-term outcomes of endoscopic resection for superficial esophageal neoplasms: comparison between EMR and ESD method. Gastrointest Endosc 2011; 73: AB201
  • 8 Deprez PH, Altwegg R, Jouret- MourinA et al. Lower recurrence rate with ESD vs. EMR for the curative treatment of esophageal superficial squamous cell carcinoma. Gastrointest Endosc 2011; 73: AB204-205
  • 9 Oyama T. Outcome of endoscopic submucosal dissection for superficial pharyngeal squamous cell carcinoma. Gastrointest Endosc 2011; 73: AB202
  • 10 Toyokawa T, Fujita I, Horii J, Tomoda J. Risk factors for perforation and delayed bleeding associated with endoscopic submucosal dissection (ESD) for early gastric neoplasms: analysis of 586 lesions. Gastrointest Endosc 2011; 73: AB149
  • 11 Shin SJ, Yu J, Choi JM et al. Risk factors for perforation of endoscopic submucosal dissection in gastric tumors. Gastrointest Endosc 2011; 73: AB399
  • 12 Caguiat K, Kaufman MS, Goodman AJ, Gress FG et al. The efficacy of EUS-FNA with immunohistochemistry staining in the analysis of gastrointestinal stromal tumors: a systematic review and meta-analysis. Gastrointest Endosc 2011; 73: AB180-181
  • 13 Sakamoto H, Kitano M, Kamata K et al. Contrast enhanced harmonic EUS imaging of submucosal tumor of gastrointestinal tract. Gastrointest Endosc 2011; 73: AB168-169
  • 14 Catalano MF, Aslam N, Taha R et al. Endoscopic ampullectomy of adenoma of the major duodenal papilla (MPD): long-term outcome. Gastrointest Endosc 2011; 73: AB270
  • 15 Sharaiha R, Gonzalez S, Ramos C et al. Endoscopic management of duodenal neoplasms and factors leading to incomplete resection and recurrence: where are we now?. Gastrointest Endosc 2011; 73: AB140
  • 16 Sörensen AS, Kayser T, Wehrmann K, Caca K. EMR in the duodenum is associated with a higher delayed bleeding rate than EMR in the colon. Gastrointest Endosc 2011; 73: AB418
  • 17 van Heel N, Haringsma J, Boot H et al. Expandable metal stents for malignant esophageal stenosis: a randomized controlled comparison of the new Evolution stent versus the Ultraflex stent. Gastrointest Endosc 2011; 73: AB158
  • 18 Repici A, Rando G, Romeo F et al. Multicenter prospective study of management of inoperable malignant esophageal strictures with a new fully covered metal stent. Gastrointest Endosc 2011; 73: AB158
    • Additional References of interest

      • Improving imaging and detection

      • 19 Moussata D, Berger F, Chauvenet M et al. Yield of neoplasia by confocal laser endomicroscopy in the chronic atrophic gastritis. Gastroenterology 2011; 140: S-748-S-749
      • 20 Uedo N, Ando T, Kato T et al. Endoscopic diagnosis of gastric intestinal metaplasia by high resolution white light videoendoscopy and chromoendoscopy with indigo carmine: a multicenter prospective randomized controlled trial. Gastroenterology 2011; 140: S-569-S-570
      • 21 Uedo N, Ng EK, Wu DC et al. Learning effect of magnifying narrow band imaging on endoscopic diagnosis of gastric intestinal metaplasia: a pilot study of Asian-Pacific International Working Group. Gastrointest Endosc 2011; 73: AB409
      • Training issues

      • 22 Parra-Blanco A, Saito Y, Yahagi N et al. Recommendations about training for colorectal endoscopic submucosal dissection in the western world. Results of a survey to experts. Gastrointest Endosc 2011; 73: AB419-AB420
      • 23 VanVilsteren FG, Pouw RE, Herrero LA et al. The learning curve of endoscopic resection of esophageal neoplasia is associated with significant complications even in a structured training program. Gastrointest Endosc 2011; 73: AB398
      • 24 Yamamoto S, Nishida T, Tsutsui S et al. How does operators’ experience of endoscopic submucosal dissection (ESD) affect short-time outcomes and procedural time of ESD for early gastric cancer?. Gastrointest Endosc 2011; 73: AB432
      • Safety issues

      • 25 Hikichi T, Sato M, Irisawa A et al. How many days in advance should proton pump inhibitor (PPI) administration be started to prevent bleeding after endoscopic submucosal dissection? Prospective randomized trial of PPI administration. Gastrointest Endosc 2011; 73: AB412
      • 26 Minamino H, Machida H, Tominaga K et al. Locoregional mitomycin C injection for post-endoscopic submucosal dissection strictures refractory to endoscopic balloon dilation. Gastrointest Endosc 2011; 73: AB279-AB280
      • Squamous cell carcinoma: EMR vs. ESD

      • 27 Fujinami H, Kudo T, Hosokawa A, Sugiyama T et al. Endoscopic submucosal dissection of superficial esophageal squamous cell neoplasia by scissors-like forceps: a safer technique. Gastrointest Endosc 2011; 73: AB286
      • 28 Sakaguchi M, Yoshinaga S, Kitada H, Hifumi M. Comparison of the outcome of endoscopic submucosal dissection (ESD) using sodium hyaluronate and needle-knife versus endoscopic aspiration mucosectomy (EAM) for esophageal squamous cell neoplasm. Gastrointest Endosc 2011; 73: AB391-392
      • Subepithelial tumors

      • 29 Darwin P, Laczek J, Hanna N et al. Ex-vivo evaluation of a prototype submucosal biopsy forceps for the diagnosis of gastric gastrointestinal stromal tumors. Gastrointest Endosc 2011; 73: AB241
      • 30 Irions EL, Sharma N, Romagnuolo J et al. Initial experience with the Echotip Procore Needle for endoscopic ultrasound (EUS) guided-diagnosis of mass lesions. Gastrointest Endosc 2011; 73: AB255
      • 31 Komanduri S, Keswani RN. Feasibility, specimen adequacy, and diagnostic accuracy of a new EUS guided core biopsy needle: a pilot study. Gastrointest Endosc 2011; 73: AB336
      • 32 Park CK. The diagnostic yield, safety and clinical impact of bite on bite biopsy for upper GI subepithelial lesions in second or third sonographic layer. Gastrointest Endosc 2011; 73: AB180
      • 33 Park WW, Kim YS, Kim HT et al. Gastrointestinal stromal tumors: an analysis of clinicopathologic outcome in a single center. Gastroenterology 2011; 140: S-876
      • 34 Tomono T, Sawaki A, Yamao K. Natural history of gastrointestinal stromal tumors (GISTs). Gastrointest Endosc 2011; 73: AB225
      • Resection of ampullary and duodenal adenomas

      • 35 Familiari P, Petrone G, Matsuoka M et al. Endoscopic snare papillectomy for ampullary neuroendocrine tumors and other rare ampullary neoplasms: a case series with long term follow up. Gastrointest Endosc 2011; 73: AB389
      • 36 Familiari P, Petrone G, Matsuoka M et al. Endoscopic snare papillectomy for early invasive cancer of the papilla of vater: a clinico-pathological analysis. Gastrointest Endosc 2011; 73: AB352-AB353
      • 37 Ito K, Fujita N, Noda Y et al. The impact of technical modification of endoscopic papillectomy for ampullary neoplasm on the occurrence of complications. Gastrointest Endosc 2011; 73: AB188
      • Evaluation of new esophageal stents

      • 38 Colaiacovo W, Fresca A, Almodova ED et al. Self-expanding metal stent (SEMS) for palliation of squamous cell carcinoma of the esophagus (SCCE): results of 80 patients. Gastrointest Endosc 2011; 73: AB281
      • 39 Hirdes MM, Vleggaar FP, Laasch HU, Siersema PD et al. Prevention of reflux using the retrofit reflux control device in patients with distally placed esophageal stents: a technical assessment. Gastrointest Endosc 2011; 73: AB280
      • 40 Hirdes MM, Vleggaar FP, Siersema PD. A new fully covered metal stent (Wallflex) to treat benign and malignant esophageal disorders: a prospective follow-up study. Gastrointest Endosc 2011; 73: AB278